Lonza Opens Cell and Gene Therapy Manufacturing Center
Lonza opened a 300,000-sf cell and gene therapy manufacturing center in April of 2018 in Pearland, Texas. The facility features eight independent cGMP modular cleanrooms with single-use bioreactors and a fully segregated fill/finish suite. Supporting the development of new therapies from initial concept through the pre-clinical, clinical, and commercialization phases, the integrated building includes research labs, offices, manufacturing and production spaces, and support.